Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 6:44 PM
Ignite Modification Date: 2025-12-25 @ 4:15 PM
NCT ID: NCT04543357
Description: MedDRA v26
Frequency Threshold: 5
Time Frame: Adverse events were monitored from Screening (Day -48 to Day -1) up to Day 56.
Study: NCT04543357
Study Brief: A Study to Evaluate AAV9 Neutralizing Antibody Seroconversion in Household Contacts.
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Participants With Potential Fordadistrogene Movaparvovec Exposure People working or living in the same household of patients who were enrolled in an interventional study of fordadistrogene movaparvovec (including study C3391003 \[NCT04281485\] and C3391002 \[not listed on ClinicalTrials.gov\]) were enrolled. 0 None 0 8 0 8 View
Serious Events(If Any):
Other Events(If Any):